| Literature DB >> 18092252 |
Emre Cecen1, Kamer Mutafoglu Uysal, Aykan Ozguven, Dilek Gunes, Gulersu Irken, Nur Olgun.
Abstract
Although veno-occlusive disease of the liver is a well-known complication of high-dose chemotherapy and bone marrow transplantation, it has rarely been observed in children who receive conventional chemotherapy. Most cases in the literature consists of children with Wilms tumor. It has been very uncommon in rhabdomyosarcoma patients until recently, although they commonly receive similar anticancer agents. Here the authors report a 2-year-old boy with rhabdomyosarcoma who developed veno-occlusive disease while receiving VAC (vincristine, actinomycin D, cyclophosphamide) chemotherapy regimen according to the IRS-IV protocol. The patient gradually recovered during 2 weeks with supportive treatment only.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18092252 DOI: 10.1080/08880010701640390
Source DB: PubMed Journal: Pediatr Hematol Oncol ISSN: 0888-0018 Impact factor: 1.969